Lars Wortmann

11PUBLICATIONS
86CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsSequence analysisMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 21, 2026
CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.

Oleksandra Herasymenko, Madhushika Silva, Galen J Correy

|Jun 20, 2025
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.

Oleksandra Herasymenko, Madhushika Silva, Abd Al-Aziz A Abu-Saleh

|Nov 05, 2024
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein.

Fengling Li, Suzanne Ackloo, Cheryl H Arrowsmith

|Feb 02, 2023
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science.

Sven Thamm, Marina K Willwacher, Gary E Aspnes

|Oct 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.

Lars Wortmann, Nico Bräuer, Simon J Holton

|Aug 24, 2021
BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.

Markus Berger, Lars Wortmann, Philipp Buchgraber

Pageof 2

Frequent Collaborators

3 joint publications

Aled Edwards

3 joint publications

Ulrich Lücking

3 joint publications

W Patrick Walters

3 joint publications

Casper Steinmann